Thrombosis
Nanogen Launches First Multiplex Protocol
Published in Blood Weekly, November 29th, 2001
Both mutations play a key role in the detection and risk assessment of certain cardiovascular disorders characterized by blood clot formation (thrombosis), potentially allowing preventive measures to be taken to reduce the chance for the onset of heart attack or stroke. This is the company's third internally validated research protocol. The anticipated users of the protocol include CLIA (Clinical Laboratory Improvement Act)...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2001-11-29)
More Articles from Blood Weekly
- Coagulation Therapy
Three-Drug Combination Provides Comprehensive Coagulation Inhibition - Hereditary Spherocytosis
Disorder Marked By Active Red Blood Cell Sodium And Potassium Transport - Blood Safety
Duke Surgeon: Use of Common Clotting Agent Should Be Restricted - Cancer Screening
Stem Cell Expression Of Guanylyl Cyclase C Affects Colorectal Cancer Tests - Multiple Myeloma
Stem Cell Mobilization Only Effective In Early Stages - Sickle Cell Anemia
Drug Helps Resolve Symptoms, Reduces Duration Of Episodes - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
